Blocking HIV Enzyme Reduces Infectivity and Slows Viral Rebound
In this NIMH-funded study, researchers developed a compound that blocked an enzyme critical for forming HIV particles, which stopped the virus from correctly forming and becoming infectious.
Related Posts
NIMH Repository and Genomics Resource for Advancing Psychiatric Genetics
September 15, 2023
The objective of this concept is to sustain, develop and enhance a centralized...
Office for Disparities Research and Workforce Diversity Webinar Series: Advancing Mental Health Disparities Research Focused on Bi+ People Through an Intersectional Lens
July 20, 2023
In this webinar, researchers will present findings on identifying modifiable...
The People Behind NIMH
August 30, 2023
At NIMH, our employees are the driving force that brings our mission to life....
Technical Assistance Webinar: Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)
July 20, 2023
This technical assistance webinar is for prospective applicants of the Notice of...